Clinical Outcomes after Intravenous Alteplase in Elderly Patients with Acute Ischaemic Stroke: A Retrospective Analysis of Patients Treated at a Tertiary Neurology Centre in England from 2013 to 2018
Intravenous thrombolysis with alteplase within 4.5 hours from symptom onset is a well-established treatment of acute ischaemic stroke (AIS). The aim was to compare alteplase for AIS between patients aged >80 and ≤80 years in our registry data, from 2013 to 2018. Mechanical thrombectomy cases were...
Guardado en:
Autores principales: | Xuya Huang, Phillip Nash, Vafa Alakbarzade, Brian Clarke, Anthony C. Pereira |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Hindawi Limited
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ddcc84811de64e1e9d19f274fa242be7 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Is tenecteplase ready to replace alteplase to treat acute ischaemic stroke? The knowns and unknowns
por: Yi Dong, et al. -
Ginkgolide With Intravenous Alteplase Thrombolysis in Acute Ischemic Stroke Improving Neurological Function: A Multicenter, Cluster-Randomized Trial (GIANT)
por: Xuting Zhang, et al.
Publicado: (2021) -
Effectiveness of alteplase in the very elderly after acute ischemic stroke
por: Yayan J
Publicado: (2013) -
Intravenous Thrombolysis for a Stroke Mimic Patient
por: Lilly Nguyen, et al.
Publicado: (2021) -
Secondary prevention medication persistence and prognosis of acute ischaemic stroke or transient ischaemic attack
por: Lei Zhang, et al.
Publicado: (2021)